文献速递基础与转化研究临床试验与 GCP

预融合稳定呼吸道合胞病毒F亚单位疫苗可激发肺病毒特异性B细胞应答

Elicitation of pneumovirus-specific B cell responses by a prefusion-stabilized respiratory syncytial virus F subunit vaccine.
PubMed 文献 · Sci Transl Med · 2022-06-22

本研究利用荧光标记探针和流式细胞术,纵向评估健康成人接种候选RSV预融合(pre-F)稳定亚单位疫苗DS-Cav1后RSV F特异性B细胞的抗原特异性和表型。结果显示首次免疫后pre-F特异性IgG+和IgA+B细胞频率快速升高,第12周二次免疫后小幅升高;pre-F特异性记忆B细胞在44周时仍高于基线。DS-Cav1还激活了可结合预融合稳定HMPV F蛋白的人偏肺病毒(HMPV)交叉反应B细胞,并在部分受试者中提高HMPV F结合抗体和中和活性。

要点

  • 首次免疫后pre-F特异性IgG+和IgA+B细胞频率快速升高,第12周二次免疫后仅小幅升高。
  • 首次免疫后几乎所有F特异性B细胞下调CD21、上调增殖标志物CD71,二次免疫后激活较弱。
  • pre-F特异性记忆B细胞(CD27+CD21+)在接种后44周仍高于基线。

核心结论

  • 接种RSV pre-F疫苗后RSV和HMPV F特异性B细胞扩增并活化,且至少维持高于基线10个月,可能有助于长期肺病毒免疫。

研究设计与样本

  • 在健康成人1期临床试验中,于首次免疫前至试验结束第44周的多个时间点采集外周血单个核细胞(PBMC),用荧光标记探针和流式细胞术评估RSV F特异性B细胞的抗原特异性和表型。

主要发现

  • 首次免疫后pre-F特异性IgG+和IgA+B细胞频率快速升高,第12周二次免疫后小幅升高。
  • 首次免疫后几乎所有F特异性B细胞下调CD21并上调增殖标志物CD71,二次免疫后激活较弱。
  • pre-F特异性记忆B细胞(CD27+CD21+)在接种后44周仍高于基线。
  • DS-Cav1接种还激活了可结合预融合稳定HMPV F蛋白的HMPV交叉反应B细胞,并在部分受试者中提高HMPV F结合抗体和HMPV中和活性。

局限性

  • 原文未报告局限性

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Respiratory syncytial virus (RSV) is a substantial cause of morbidity and mortality globally. A candidate RSV prefusion (pre-F)-stabilized subunit vaccine, DS-Cav1, has previously been shown to elicit potent and durable neutralizing activity in a phase 1 clinical trial in healthy adults. Here, we used fluorescently labeled probes and flow cytometry to evaluate the antigen specificity and phenotype of RSV F-specific B cells longitudinally after DS-Cav1 immunization. Peripheral blood mononuclear cells (PBMCs) collected at time points before the first immunization through the end of the trial at 44 weeks were assessed by flow cytometry. Our data demonstrate a rapid increase in the frequency of pre-F-specific IgG+ and IgA+ B cells after the first immunization and a modest increase after a second immunization at week 12. Nearly all F-specific B cells down-regulated CD21 and up-regulated the proliferation marker CD71 after the first immunization, with less pronounced activation after the second immunization. Memory B cells (CD27+CD21+) specific for pre-F remained elevated above baseline at 44 weeks after vaccination. DS-Cav1 vaccination also activated human metapneumovirus (HMPV) cross-reactive B cells capable of binding prefusion-stabilized HMPV F protein and increased HMPV F-binding antibodies and neutralizing activity for HMPV in some participants. In summary, vaccination with RSV pre-F resulted in the expansion and activation of RSV and HMPV F-specific B cells that were maintained above baseline for at least 10 months and could contribute to long-term pneumovirus immunity.

来源:Sci Transl Med,查看原文。版权归原作者所有。

引用

  1. Phung E, Chang LA, Mukhamedova M, et al. Elicitation of pneumovirus-specific B cell responses by a prefusion-stabilized respiratory syncytial virus F subunit vaccine. Sci Transl Med. 2022. PMID: 35731888. doi:10.1126/scitranslmed.abo5032

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。